# 18F-FDG PET Imaging in Cardiac Sarcoidosis

> **NCT01764191** · — · APPROVED_FOR_MARKETING · sponsor: **British Columbia Cancer Agency**

## Conditions studied

- Cardiac Sarcoidosis

## Interventions

- **OTHER:** 18F-Fluorodeoxyglucose (18F-FDG) PET/CT

## Key facts

- **NCT ID:** NCT01764191
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764191, "18F-FDG PET Imaging in Cardiac Sarcoidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01764191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*